🔎 Trials Near Me

Hjem › Crohns sykdom › Georgia › Atlanta

Kliniske studier for Crohns sykdom i Atlanta, GA

17 studier for Crohns sykdom søker deltakere på steder i og rundt Atlanta (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RekruttererFase 3
  • Morehouse School Of Medicine ( Site 5071), Atlanta
Alder 16 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

RekruttererFase 4
  • Digestive Healthcare of Georgia, Atlanta
  • AGA GA Research LLC, Atlanta
Alder 18 til 80 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06581328

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • Emory University, Atlanta
  • Children's Center for Digestive Health Care, Atlanta
Alder 2 til 17 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05923073

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 2
  • Emory University Hospital, The Emory Clinic, Atlanta
  • Atlanta Center For Gastroenterology, P.C., Decatur · 6 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06233461

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • Morehouse School of Medicine, Atlanta
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07499232

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

RekruttererFase 3
  • Emory University, Atlanta
  • Children's Center for Digestive Healthcare, Atlanta
Alder 3 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06663332

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 2/3
  • Emory University, Atlanta
  • Children's Center for Digestive Health Care, Atlanta
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07196722

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • Atlanta Gastroenterology Associates-Site Number: 8400109, Atlanta
Alder 16 til 80 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07184931

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

RekruttererFase 3
  • Emory University School of Medicine, Atlanta
  • Children's Center for Digestive Health Care, LLC, Atlanta
Alder 2 til 19 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT04844606

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

RekruttererFase 2
  • Atlanta Gastroenterology Associates - Peachtree Dunwoody, Atlanta
Alder 18 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07483099

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

RekruttererFase 2
  • Atlanta Gastroenterology Specialists, PC, Atlanta
  • Atlanta Gastroenterology Associates (Part of United Digestive), Atlanta
Alder 18 til 85 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06226883

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

RekruttererFase 2
  • Atlanta Gastroenterology Associates - Peachtree Dunwoody, Atlanta
Alder 18 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07483073

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

RekruttererFase 3
  • Emory University, Atlanta
  • Children's Center for Digestive Health Care, LLC, Atlanta
Alder 2 til 17 · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05509777

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

RekruttererFase 4
  • Emory University, Atlanta
Alder 6 til 17 · Alle kjønn · Oppdatert 27. mai 2026 · NCT05781152

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

RekruttererFase 3
  • Childrens Center For Digestive Healthcare, Atlanta
Alder 2 og eldre · Alle kjønn · Oppdatert 7. mai 2026 · NCT05442567

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

RekruttererFase 3
  • Childrens Center For Digestive Healthcare, Atlanta
Alder 2 til 17 · Alle kjønn · Oppdatert 5. mai 2026 · NCT04779320

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RekruttererFase 2
  • Mirador Therapeutics Selected Site, Atlanta
Alder 18 til 80 · Alle kjønn · Oppdatert 12. mar. 2026 · NCT07113522

Crohns sykdom-studier i andre byer

Andre studier i Atlanta

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.